Kuros Biosciences logo

Lead Biomaterials Product Development Engineer

Kuros Biosciences

Bilthoven
Full-time
5-10 years experience
On-site

Key Skills

Biomaterials Development
Product Development
Bone Void Fillers
Orthobiologics
Project Leadership
Cross-Functional Collaboration
Design History File (DHF) Management
Verification and Validation (V&V)
Vendor Coordination
Contract Manufacturer Coordination
Design Transfer
Scalable Manufacturing
Regulatory Compliance
Product Performance

Job Description

Kuros Biosciences in Bilthoven, the Netherlands, is seeking a Senior Product Development Engineer to lead development of bone void filler and orthobiologics from concept to launch. The role blends hands-on biomaterials work with project leadership across cross-functional teams. You will own DHF, drive V&V, coordinate vendors and contract manufacturers, and ensure design transfer to scalable manufacturing, with a focus on regulatory compliance and robust product performance.

Core Responsibilities

Lead the development of bone void filler and orthobiologics from concept through product launch, combining hands-on biomaterials work with cross-functional project leadership. Own the Design History File, drive verification and validation, coordinate vendors and contract manufacturers, and ensure design transfer to scalable manufacturing while maintaining regulatory compliance and product performance.

Requirements

The posting indicates a senior-level product development role requiring expertise in biomaterials and medical device product development. It emphasizes project leadership, design controls, verification and validation, manufacturing transfer, vendor coordination, and regulatory compliance; no specific education or years-of-experience requirement is stated.

About Kuros Biosciences

Industry: Medical Equipment Manufacturing

Company size: 51-200 employees

OUR PURPOSE Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies. OUR CREDENTIALS Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team. To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing. • Listing on the 𝗦𝗜𝗫 𝗦𝘄𝗶𝘀𝘀 𝗘𝘅𝗰𝗵𝗮𝗻𝗴𝗲 under the symbol KURN since 2016 • A commercial & research footprint that spans >𝟮𝟬 𝗺𝗮𝗿𝗸𝗲𝘁𝘀 • Dozens of 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗻𝗱 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗲𝘅𝗽𝗲𝗿𝘁 𝗮𝗱𝘃𝗶𝘀𝗲𝗿𝘀 • >𝟮𝟱 orthobiologics-related 𝗽𝗮𝘁𝗲𝗻𝘁𝘀 • >𝟰𝟬𝟬 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗲𝗱 in Level I, randomized controlled clinical trials • >𝟮𝟬 well-controlled 𝗟𝗲𝘃𝗲𝗹 𝗜-𝗜𝗩 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗲𝗱, including 6 that are complete¹ • Published Level I evidence published in 𝑆𝑝𝑖𝑛𝑒 CONTACT KUROS TO FIND OUT MORE >>>>

Added Today